Deciduous Therapeutics
Home - Deciduous Therapeutics Inc.
United States · $5.8M raised
- Business Model
- B2B
- Website
- deciduoustx.com
- Total Funding
- $5.8M
- Last Round
- $5.8M Series BJan 2023
- Rounds
- 3
About
Biotech developing immune-modulatory therapies targeting senescent cells to extend healthy human lifespan.
Summary
Deciduous Therapeutics is a Biotech company based in United States. It has raised $5.8M in total across 3 rounds, most recently a $5.8M Series B round in Jan 2023. Investors include CRV (Charles River) and LongGame.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2023
Sign up to see all 3 rounds
Seed through Series B — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/deciduous-therapeutics"><img src="https://indexed.vc/api/badge/company/deciduous-therapeutics" alt="Deciduous Therapeutics on Indexed.vc" width="260" height="76" /></a>